Supurva Healthcare Group Stock Debt To Equity
| SPRV Stock | USD 0.0001 0.0001 50.00% |
Supurva Healthcare Group fundamentals help investors to digest information that contributes to Supurva Healthcare's financial success or failures. It also enables traders to predict the movement of Supurva Pink Sheet. The fundamental analysis module provides a way to measure Supurva Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Supurva Healthcare pink sheet.
Supurva |
Supurva Healthcare Group Company Debt To Equity Analysis
Supurva Healthcare's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Supurva Healthcare Group has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Supurva Fundamentals
| Net Income | (304.78 K) | |||
| Total Debt | 740.83 K | |||
| Cash Flow From Operations | (329.58 K) | |||
| Beta | 28.84 | |||
| Total Asset | 6.81 K | |||
| Net Asset | 6.81 K |
About Supurva Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Supurva Healthcare Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Supurva Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Supurva Healthcare Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Supurva Pink Sheet Analysis
When running Supurva Healthcare's price analysis, check to measure Supurva Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Supurva Healthcare is operating at the current time. Most of Supurva Healthcare's value examination focuses on studying past and present price action to predict the probability of Supurva Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Supurva Healthcare's price. Additionally, you may evaluate how the addition of Supurva Healthcare to your portfolios can decrease your overall portfolio volatility.